EUVIMEDEUVIMED entdecken
Crossref

Risk stratification based on changes in the standard maximal uptake value on PET/CT and the plasma Epstein‒Barr virus (EBV) DNA status after two cycles of chemotherapy for extranodal NK-/T-cell lymphoma

Quanguang Ren, Yue Cui, Zhao Wang, Xiaojie Fang, Meiting Chen, Zegeng Chen, Tongyu Lin, Yongsheng Jiang, He Huang

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-06149-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Quanguang Ren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Lymphoma, Extranodal NK-T-Cell, Herpesvirus 4, Human, DNA, Viral, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Youth Program, Natural Science Foundation of Hubei Province, People's Republic of China, Youth Program, Natural Science Foundation of Hubei Province, People’s Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Extranodal NK-T-CellHerpesvirus 4, HumanDNA, ViralPositron Emission Tomography Computed TomographyAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleMiddle AgedAdultRetrospective StudiesAgedEpstein-Barr Virus InfectionsYoung AdultPrognosis

Stichwörter der Autor:innen

EBVDNAENKTLLymphomaPET/CTPrognosisTreatment response

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Medical Oncology, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ysjiang.china@163.com.
  • Department of Medical Oncology, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. huanghe@sysucc.o…

Förderung

  • Youth Program, Natural Science Foundation of Hubei Province, People's Republic of China
  • Youth Program, Natural Science Foundation of Hubei Province, People’s Republic of China

Zitieren

APA

Ren, Q., Cui, Y., Wang, Z., Fang, X., Chen, M., Chen, Z., Lin, T., Jiang, Y., & Huang, H. (2024). Risk stratification based on changes in the standard maximal uptake value on PET/CT and the plasma Epstein‒Barr virus (EBV) DNA status after two cycles of chemotherapy for extranodal NK-/T-cell lymphoma. Annals of Hematology. https://doi.org/10.1007/s00277-024-06149-1

Vancouver

Ren Q, Cui Y, Wang Z, Fang X, Chen M, Chen Z, et al. Risk stratification based on changes in the standard maximal uptake value on PET/CT and the plasma Epstein‒Barr virus (EBV) DNA status after two cycles of chemotherapy for extranodal NK-/T-cell lymphoma. Annals of Hematology. 2024. doi:10.1007/s00277-024-06149-1

BibTeX
@article{Ren2024,
  author = {Ren, Quanguang and Cui, Yue and Wang, Zhao and Fang, Xiaojie and Chen, Meiting and Chen, Zegeng and Lin, Tongyu and Jiang, Yongsheng and Huang, He},
  title = {Risk stratification based on changes in the standard maximal uptake value on PET/CT and the plasma Epstein‒Barr virus (EBV) DNA status after two cycles of chemotherapy for extranodal NK-/T-cell lymphoma},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-06149-1}
}
Kostenlos starten →